Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal vs IV Dexmedetomidine in FESS
NCT06081933Phase 4Unknown
- Sponsor
- Kafrelsheikh University
- Start
- Dec 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in chronic rhinosinusitis (CRS), sponsored by Kafrelsheikh University. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT06081933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06081933.